ICAD vs. NUTX

Last updated Jun 3, 2026

ICAD (iCAD, Inc.) and NUTX (Nutex Health Inc) are both stocks. Both operate in the Health Information Services industry within the Healthcare sector. At a 0.13 correlation, their price movements are largely independent.

Performance

ICAD vs. NUTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iCAD, Inc. (ICAD) and Nutex Health Inc (NUTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ICAD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NUTX

• 1D: -2.34%
• 1M: -10.42%
• YTD: -24.05%
• 6M: -3.65%
• 1Y: -25.56%
• 3Y*: 22.61%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ICAD vs. NUTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
ICAD iCAD, Inc.	0.00%	111.48%	3.39%	-3.28%	-56.64%
NUTX Nutex Health Inc	-24.05%	419.47%	17.37%	-90.53%	-95.25%

Correlation

The correlation between ICAD and NUTX is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (All Time) Calculated using the full available price history since Apr 5, 2022	0.13

The correlation between ICAD and NUTX shifts across timeframes, from -0.07 (1 year) to 0.13 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM) ICAD : $19.53M NUTX : $879.95M
Gross Profit (TTM) ICAD : $16.77M NUTX : $417.67M
EBITDA (TTM) ICAD : -$4.84M NUTX : $275.94M

Return for Risk

ICAD vs. NUTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUTX

NUTX Risk / Return Rank: 30
NUTX Sharpe Ratio Rank: 29
NUTX Sortino Ratio Rank: 36
NUTX Omega Ratio Rank: 35
NUTX Calmar Ratio Rank: 24
NUTX Martin Ratio Rank: 27

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ICAD vs. NUTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iCAD, Inc. (ICAD) and Nutex Health Inc (NUTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ICAD	NUTX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.27	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.46	—

Drawdowns

Drawdown Indicators

	ICAD	NUTX	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.93%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-54.32%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-94.36%	—
Current Drawdown Current decline from peak	—	-97.92%	—
Average Drawdown Average peak-to-trough decline	—	-97.27%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	36.42%	—

Volatility

Volatility by Period

	ICAD	NUTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	25.88%	—
Volatility (6M) Calculated over the trailing 6-month period	—	67.20%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	95.75%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	133.36%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	133.36%	—

Dividends

ICAD vs. NUTX - Dividend Comparison

Neither ICAD nor NUTX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ICAD and NUTX in my portfolio?

ICAD and NUTX have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.